FDA finalizes total-THC framework for hemp products ahead of November 2026 deadline
The rule replaces the delta-9-only standard from the 2018 Farm Bill with a total-THC measurement, effectively banning most intoxicating hemp products at the federal level.
The FDA published its final framework for regulating hemp-derived products under the new total-THC standard, setting the stage for a major market shakeup when the rule takes effect in November 2026. The regulation replaces the delta-9-only measurement from the 2018 Farm Bill with a total-THC calculation that captures all intoxicating THC isomers.
What changes
Under the 2018 Farm Bill, legal hemp was defined as cannabis containing less than 0.3% delta-9 THC by dry weight. This narrow definition inadvertently created a loophole: manufacturers could produce products high in delta-8 THC, delta-10 THC, THC-O, and other psychoactive isomers while remaining technically "hemp."
The new rule changes the measurement to total THC — the combined concentration of all THC isomers and their acid precursors. Products exceeding 0.3% total THC will be classified as marijuana under federal law, regardless of their delta-9 content.
The practical impact
The rule effectively eliminates the intoxicating hemp product market that has grown into an estimated $20-30 billion industry since 2018. Products affected include:
- Delta-8 THC gummies, vapes, and tinctures
- THC-O and other synthetic THC isomers
- High-potency hemp flower bred to maximize total cannabinoid content
- Live resin and concentrate products derived from hemp
Non-intoxicating CBD products — those containing minimal THC — are largely unaffected, provided they fall below the 0.3% total-THC threshold.
State-level implications
Many states have already moved ahead of the federal timeline. Texas, for example, banned intoxicating hemp flower and vape products in March 2026. Other states including New York, California, and Colorado have implemented their own hemp product regulations.
However, the federal rule creates a national floor. States can be more restrictive, but they cannot be more permissive — once the November deadline passes, intoxicating hemp products will be federally prohibited regardless of state law.
Industry response
The hemp industry is deeply divided. Companies focused on CBD wellness products have largely supported the change, arguing that intoxicating products created confusion in the marketplace and undermined consumer trust. The U.S. Hemp Roundtable called the rule "a necessary step toward a mature, regulated industry."
Conversely, companies that built their business on intoxicating hemp products have filed legal challenges. Several lawsuits argue that the FDA overstepped its authority and that Congress — not the agency — should determine the legal definition of hemp.
What's next
The November 2026 effective date gives manufacturers roughly seven months to reformulate or exit the market. The FDA has indicated it will provide a 90-day enforcement grace period for products manufactured before the deadline, but new production of non-compliant products must cease immediately.
For consumers, the practical effect is straightforward: the delta-8 gummies and hemp vapes available at gas stations and smoke shops today will be federally illegal by the end of the year.